Singla, N., Satyanarayana, S., Sachdeva, K.S., Van den Bergh, R., Reid, T., Tayler- Smith, K., et al. (2014) Impact of Introducing the Line Probe Assay on time to Treatment Initiation of MDR-TB in Delhi, India. PLoS One, 9, e102989.

has been cited by the following article:

• TITLE: Treatment Initiation among Patients with Multidrug Resistant Tuberculosis in Bhopal District, India

  AUTHORS: Hemant Deepak Shewade, Arun M. Kokane, Akash Ranjan Singh, Manoj Verma, Malik Parmar, Sanjay Singh Chahar, Manoj Tiwari, Sheeba Naz Khan, Mukesh Nagar, Sanjai Kumar Singh, Pradeep Kumar Mehra, Ajay M. V. Kumar

  KEYWORDS: Multidrug-Resistant Tuberculosis, Operational Research, Pre-Treatment Attrition, Diagnosis and Treatment Pathway, Initial Loss to Follow-Up

  JOURNAL NAME: Journal of Tuberculosis Research, Vol.5 No.4, November 10, 2017

  ABSTRACT: Revised national tuberculosis control programme in India has limited co-hort-wise information about what happens to patients diagnosed with multidrug resistant TB (MDR-TB). We determined the pre-treatment loss to follow-up (non-initiation of treatment by programme within 6 months of diagnosis) and time from diagnosis to treatment initiation in Bhopal district, central India (2014). Pre-treatment loss to follow-up was 13% (0.95 CI: 7%, 23%), not significantly different from the national estimates (18%) and median time to initiate treatment was seven days, lower than that reported elsewhere in the country. Bhopal was performing well with reference to time to treatment initiation in programmatic settings.